FirstEnergy Corp., together with its subsidiaries, engages in the generation, distribution, and transmission of electricity in the United States. It operates through Distribution, Integrated, and Stand-Alone Transmission segments. The company owns and operates coal-fired, nuclear, hydroelectric, wind, and solar power generating facilities. It operates 252,244 distribution line miles and 24,143 transmission line miles, including overhead pole line and underground conduit carrying primary, secondary, and street lighting circuits. The company serves customers in Ohio, Pennsylvania, New Jersey, West Virginia, Maryland, and New York. FirstEnergy Corp. was incorporated in 1996 and is headquartered in Akron, Ohio.

FirstEnergy Corp.

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Applied Materials (AMAT – Research Report), Cohere...

Analysts Conflicted on These Technology Names: Applied Materials (AMAT), Coherent Corp (COHR) and Paysafe (PSFE)

An update from Brookside Energy ( ($AU:BRK) ) is now available. Brookside Energy Limited continues its on-market share buy-back of ordinary fully p...

Brookside Energy Continues On-Market Share Buy-Back Program

Ethereum (ETH-USD) faced a tough week as selling pressure built up across the crypto market. Indeed, Ethereum fell more than 30% over the past week...

Can Ethereum Rebounds from Lows, but ETF Flows Still Point to CautionCan

Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study Overview: Pfizer is running an early-stage clinical trial titled “An I...

Pfizer Halts Early-Stage Trial for PF-07258669 in Older Adults: What Investors Should Know

Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Advances Mid-Stage Trial of New Obesity Drug PF-07976016 Study Overvi...

Pfizer Completes Mid-Stage Trial of New Obesity Drug Candidate PF-07976016

Ethereum (ETH-USD) and its corresponding exchange-traded funds (ETFs) are enduring a high-stress test on Friday as the broader crypto market enters...

Ethereum ETFs Hemorrhage $81M as Investors Reach Breaking Point Near $1,900 Support

An update from JFE Holdings ( ($JP:5411) ) is now available. JFE Holdings reported weaker results for the first nine months of fiscal 2025, with re...

JFE Holdings Posts Profit Slide in Q3 FY2025 and Lowers Payout Versus Prior Year

Biontech Se Sponsored Adr ($BNTX), Pfizer Inc ($PFE) announced an update on their ongoing clinical study. modRNA shingles pursuit from Pfizer and B...

Pfizer and BioNTech Pause modRNA Shingles Ambitions

The latest update is out from Fuelcell Energy ( ($FCEL) ). FuelCell Energy disclosed that its employment relationship with former Executive Vice Pr...

FuelCell Energy Finalizes Separation Terms for Former Counsel

BMO Capital analyst Evan Seigerman maintained a Buy rating on Pfizer yesterday and set a price target of $30.00. The company’s shares closed yester...

BMO Capital Reaffirms Their Buy Rating on Pfizer (PFE)

In a report released today, Erika Najarian from UBS reiterated a Hold rating on Synchrony Financial, with a price target of $82.00. Najarian covers...

UBS Reaffirms Their Hold Rating on Synchrony Financial (SYF)

Scotiabank analyst Louise Chen maintained a Buy rating on Pfizer today and set a price target of $30.00. Chen covers the Healthcare sector, focusin...

Scotiabank Reaffirms Their Buy Rating on Pfizer (PFE)

In a report released today, Thomas Chauvet from Citi maintained a Hold rating on Salvatore Ferragamo S.p.A., with a price target of €7.10. Accordin...

Citi Sticks to Its Hold Rating for Salvatore Ferragamo S.p.A. (0P52)

Analysts fell to the sidelines weighing in on Pfizer (PFE – Research Report) and Avidity Biosciences (RNA – Research Report) with neutral ratings, ...

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Avidity Biosciences (RNA)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Ultragenyx Pharmaceutical (RARE – Research Report) and Pfizer (PF...

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Pfizer (PFE)

5E Advanced Materials, Inc. ( ($FEAM) ) just unveiled an update. On February 3, 2026, 5E Advanced Materials closed an upsized, oversubscribed U.S. ...

5E Advanced Materials Raises $36 Million in Equity Offering

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Invivyd (IVVD – Research Report) and Pfizer (PFE –...

Analysts Offer Insights on Healthcare Companies: Invivyd (IVVD) and Pfizer (PFE)

Drugmaker Pfizer ($PFE) is set to report its Q4 earnings results on February 3 before the market opens. Analysts are expecting earnings per share t...

Is Pfizer (PFE) a Good Stock to Buy before Earnings?

Ferrari ( ($IT:RACE) ) has issued an announcement. On February 2, 2026, Ferrari reported the latest progress under the €250 million first tranche o...

Ferrari Expands Treasury Position with €57.6 Million in Share Buybacks by January 30, 2026

Barclays analyst Julien Roch maintained a Buy rating on MFE-MediaForEurope NV Class B today and set a price target of €5.50. Roch covers the Commun...

MFE-MediaForEurope NV Class B (0NE1) Receives a Buy from Barclays

In a report released today, Julien Roch from Barclays maintained a Buy rating on MFE-MediaForEurope NV Class A, with a price target of €4.15. Accor...

MFE-MediaForEurope NV Class A (MFEA) Gets a Buy from Barclays

Fevertree Drinks ( ($GB:FEVR) ) just unveiled an announcement. Fever-Tree has confirmed that its total issued share capital stands at 115,811,855 o...

Fever-Tree Confirms Total Voting Rights at 115.8 Million Shares

Companies in the Industrial Goods sector have received a lot of coverage today as analysts weigh in on Canadian National Railway (CNI – Research Re...

Analysts Conflicted on These Industrial Goods Names: Canadian National Railway (CNI) and Fuji Electric Co (OtherFELTF)

U.S. stocks ended the week lower as pressure from rates and commodities weighed on risk appetite. The Dow Jones Industrial Average (DJIA) fell 0.36...

The Week That Was, The Week Ahead: Macro and Markets, Feb. 1

In a report released on January 30, Prieto Luis from Kepler Capital maintained a Buy rating on Ferrovial, with a price target of €60.30. The compan...

Ferrovial (0P2N) Receives a Rating Update from a Top Analyst

In a report released on January 29, Richard Withagen from Kepler Capital maintained a Hold rating on Fevertree Drinks, with a price target of p825....

Kepler Capital  Sticks to Their Hold Rating for Fevertree Drinks (FQVTF)

Barclays analyst Claudia Gaspari maintained a Buy rating on Munich Reinsurance today and set a price target of €613.00. According to TipRanks, Gasp...

Munich Reinsurance (0KFE) Gets a Buy from Barclays

Brookside Energy ( ($AU:BRK) ) has issued an announcement. Brookside Energy reported a solid December 2025 quarter, with its Bruins well moving int...

Brookside Energy Lifts Cash Reserves as SWISH Production and Buy-Back Drive Shareholder Focus

Brand Engagement Network, ENvue Medical Inc., and Tian Ruixiang Holdings are the 3&nbsp;Penny Stocks&nbsp;to watch on January 29, 2026, based on&nb...

3 Penny Stocks to Watch Now, 1/29/26

Far East Gold Ltd ( ($AU:FEG) ) has shared an announcement. Far East Gold reported a highly active December 2025 quarter at its Idenburg Project, w...

Far East Gold Extends High-Grade Gold Zones at Idenburg’s Sua and North Bermol Prospects

Teuton Resources ( ($TSE:TUO) ) just unveiled an update. Teuton Resources reported assay results from its 2025 inaugural diamond drill program on t...

Teuton Confirms Porphyry-Style Copper System at Ram Property in B.C.’s Golden Triangle

Teuton Resources ( ($TSE:TUO) ) has shared an update. Teuton Resources reported that its joint venture partner Tudor Gold has released a new 2026 m...

Teuton JV Partner Boosts Treaty Creek Gold Resource and Eyes Underground Production

In a report released today, Chris Huang from UBS maintained a Hold rating on Salvatore Ferragamo S.p.A., with a price target of €7.50. According to...

UBS Keeps Their Hold Rating on Salvatore Ferragamo S.p.A. (0P52)

The Trump administration has announced the names of 15 drugs targeted for Medicare price negotiations for 2028. The new list of branded medications...

CMS Names Pfizer, Eli Lilly, and AbbVie Drugs for Third Medicare Price Talks

The latest announcement is out from JFE Holdings ( ($JP:5411) ). JFE Holdings has announced a change in its top leadership, appointing Toshihiro Ta...

JFE Holdings Announces Leadership Change With New Representative Director

Pantera Minerals Ltd. ( ($AU:PFE) ) has issued an update. Pantera Minerals has completed the A$40 million divestment of its Smackover Lithium Proje...

Pantera Minerals Locks In $40m Lithium Sale and Pivots to U.S. Antimony-Silver Push

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Frequency Electronics (FEIM – Research Report), In...

Analysts Offer Insights on Technology Companies: Frequency Electronics (FEIM), International Business Machines (IBM) and HubSpot (HUBS)

Citi analyst Geoff Meacham maintained a Hold rating on Pfizer today and set a price target of $26.00. According to TipRanks, Meacham is a 5-star an...

Citi Keeps Their Hold Rating on Pfizer (PFE)

Synchrony Financial ( ($SYF) ) has provided an announcement. Synchrony Financial furnished unaudited monthly charge-off and delinquency statistics ...

Synchrony Financial Releases December 2025 Credit Performance Metrics

Oppenheimer analyst maintained a Hold rating on Franklin Electric Co yesterday. The company’s shares closed yesterday at $100.41. Currently, the an...

Oppenheimer Keeps Their Hold Rating on Franklin Electric Co (FELE)

Brookside Energy ( ($AU:BRK) ) has shared an announcement. Brookside Energy Limited has updated the market on the progress of its on-market share b...

Brookside Energy Issues Daily Update on On-Market Share Buy-Back

Ferrari ( ($IT:RACE) ) has shared an update. On January 26, 2026, Ferrari reported the latest progress in its €250 million share buyback program, w...

Ferrari Expands Treasury Stake as €3.5 Billion Buyback Program Gains Pace

Pfizer Inc ($PFE), Biontech Se Sponsored Adr ($BNTX) announced an update on their ongoing clinical study. Pfizer-BioNTech Advance Combo Vaccine Str...

Pfizer and BioNTech Move Closer to a Single-Shot Flu–COVID Vaccine: What Investors Should Watch

UBS analyst Cristian Nedelcu maintained a Buy rating on Ferrovial today and set a price target of €65.00. Nedelcu covers the Industrials sector, fo...

Ferrovial (0P2N) Gets a Buy from UBS

Jefferies analyst James Grzinic reiterated a Hold rating on Ferrari yesterday and set a price target of €300.00. According to TipRanks, Grzinic is ...

Jefferies Sticks to Its Hold Rating for Ferrari (RACE)

Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study Overview: Pfizer is launching a new early-stage trial titled “AN INTER...

Pfizer’s New Autoimmune Candidate PF-08065010 Enters Phase 1: What Investors Should Watch

Danish drugmaker Novo Nordisk’s ($NVO) shares rose about 3% as data showed that over 18,000 prescriptions were issued in the first week of the laun...

Novo Nordisk Stock (NVO) Gains on Obesity Pill Demand as Goldman Flags Earnings Upside

First Real Estate Investment ( ($SG:AW9U) ) has shared an announcement. First REIT has issued 465,478 new units to its manager, First REIT Manageme...

First REIT Issues New Units to Manager as Divestment Fee for Indonesian Asset Sale

In a report released today, Aaron Guy from Citi reiterated a Buy rating on Safestore Holdings, with a price target of £10.50. According to TipRanks...

Citi Sticks to Its Buy Rating for Safestore Holdings (SAFE)

Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study Overview Pfizer is running a Phase 1 study titled “PHASE 1, OPEN-LABEL...

Pfizer Advances PF-07248144 With New Drug–Interaction Study, Signaling Quiet Pipeline Progress

In a report released today, Piral Dadhania from RBC Capital maintained a Buy rating on Ferrari, with a price target of €435.00. According to TipRan...

RBC Capital Reaffirms Their Buy Rating on Ferrari (RACE)

Goldman Sachs analyst Andrew Baker maintained a Hold rating on Munich Reinsurance today and set a price target of €574.00. Baker covers the Financi...

Goldman Sachs Reaffirms Their Hold Rating on Munich Reinsurance (0KFE)

QuickFee Ltd. ( ($AU:QFE) ) has issued an update. QuickFee reported flat quarterly revenue of A$4.2 million for Q2 FY26 on a normalised basis, with...

QuickFee Holds Revenue Steady as Core Fee-Funding Business Delivers Strong Margins

Goldman Sachs analyst downgraded Fuji Electric Co to a Sell today and set a price target of Yen11,800.00. The word on The Street in general, sugges...

Goldman Sachs downgrades Fuji Electric Co (FELTF) to a Sell

Canadian Life Companies Split Corp. Class A ( ($TSE:LFE) ) has issued an update. Canadian Life Companies Split Corp. has declared its regular month...

Canadian Life Companies Split Corp. Announces Monthly Dividends for Class A and Preferred Shares

Ferrexpo ( ($GB:FXPO) ) has issued an announcement. Ferrexpo has temporarily suspended its Ukrainian operations and placed part of its workforce on...

Ferrexpo Halts Ukrainian Operations Again Amid Power Infrastructure Attacks

In a report released on January 16, Sam Reid from Wells Fargo maintained a Buy rating on Ferguson PLC, with a price target of $280.00. The company’...

Ferguson PLC (FERG) Receives a Buy from Wells Fargo

Swiss drugmaker Novartis ($NVS) has said it expects to reduce its U.S. tariff exposure to a minimum by halfway through this year due to its agreeme...

Novartis Stock (NVS) Holds on Upbeat View of Tariff Exposure amid U.S.-EU Tension

Companies in the Materials sector have received a lot of coverage today as analysts weigh in on JFE Holdings (JFEEF – Research Report) and Warrior ...

Analysts Have Conflicting Sentiments on These Materials Companies: JFE Holdings (OtherJFEEF) and Warrior Met Coal (HCC)

In a report released on January 15, Hao Xin from J.P. Morgan maintained a Buy rating on JFE Holdings, with a price target of Yen2,200.00. The compa...

JFE Holdings (JFEEF) Gets a Buy from J.P. Morgan

In a report released on January 15, from Daiwa maintained a Hold rating on JFE Holdings, with a price target of Yen2,200.00. The company’s shares c...

JFE Holdings (JFEEF) Gets a Hold from Daiwa

Oceanic Iron Ore ( ($TSE:FEO) ) just unveiled an announcement. Oceanic Iron Ore has reported Phase 2 metallurgical testwork results from its Hopes ...

Oceanic Iron Ore Confirms Premium DR-Grade Concentrate Potential at Hopes Advance

J.P. Morgan analyst Kamran Hossain maintained a Buy rating on Munich Reinsurance on January 16. The company’s shares closed last Friday at €527.00....

J.P. Morgan Sticks to Its Buy Rating for Munich Reinsurance (0KFE)

U.S. stocks finished the week essentially flat as a semiconductor-led bid was offset by softer bank performance and a steady drumbeat of policy hea...

The Week That Was, The Week Ahead: Macro and Markets, Jan. 18

The latest announcement is out from Refex Industries Limited ( ($IN:REFEX) ). Refex Industries Limited has announced that it will hold an earnings ...

Refex Industries Schedules Q3 FY26 Earnings Call for 21 January

In a report released on January 15, Julian Livingston-Booth from Kepler Capital maintained a Hold rating on Safestore Holdings, with a price target...

Kepler Capital  Remains a Hold on Safestore Holdings (SAFE)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on MBX Biosciences, Inc. (MBX – Research Report), Tel...

Analysts Offer Insights on Healthcare Companies: MBX Biosciences, Inc. (MBX), Teladoc (TDOC) and Pfizer (PFE)

Barclays analyst Ivan Bokhmat maintained a Buy rating on Munich Reinsurance today and set a price target of €616.00. Bokhmat covers the Financial s...

Barclays Sticks to Its Buy Rating for Munich Reinsurance (0KFE)

In a report released yesterday, Matthew Bouley from Barclays maintained a Buy rating on Ferguson PLC. The company’s shares closed yesterday at $249...

Ferguson PLC (FERG) Gets a Buy from Barclays

Brookside Energy ( ($AU:BRK) ) has shared an update. Brookside Energy Limited has provided an updated notification on its ongoing on‑market share b...

Brookside Energy Updates Market on Progress of On‑Market Share Buy-Back

Ferrari ( ($IT:RACE) ) has issued an announcement. On January 15, 2026, Ferrari N.V. published its 2026 corporate calendar, detailing the schedule ...

Ferrari Sets 2026 Financial Results and AGM Schedule

Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study OverviewThis Pfizer study, officially titled “A 2 CohORT, SINGLE DOSE,...

Pfizer Advances Prazosin Manufacturing Shift With New Bioequivalence Study

Femasys ( ($FEMY) ) has provided an update. On July 16, 2025, Femasys Inc. was notified by Nasdaq that its common stock had failed to meet the $1.0...

Femasys Receives Nasdaq Extension to Regain Listing Compliance

Jefferies analyst Philip Kett maintained a Hold rating on Munich Reinsurance on January 13 and set a price target of €600.00. The company’s shares ...

Munich Reinsurance (0KFE) Gets a Hold from Jefferies

Embracer Group AB ( ($SE:EMBRAC.B) ) just unveiled an update. Embracer Group has appointed veteran games and entertainment executive Lee Guinchard ...

Embracer Names Lee Guinchard COO to Steer Shift Toward Fellowship Entertainment

An update from Brookside Energy ( ($AU:BRK) ) is now available. Brookside Energy Limited has updated the market on its ongoing on‑market share buy-...

Brookside Energy Reports Daily Progress on On-Market Share Buy-Back

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cytokinetics (CYTK – Research Report) and Pfizer (...

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Pfizer (PFE)

Danish pharmaceutical giant Novo Nordisk ($NVO) is open to big or small deals to bolster its obesity drug portfolio. In an interview with Bloomberg...

Novo Nordisk (NVO) Is Open to M&A to Bolster Obesity Drug Portfolio

Far East Gold Ltd ( ($AU:FEG) ) has issued an announcement. Far East Gold has announced a reshuffle in its senior corporate roles, with company sec...

Far East Gold Reshapes Finance and Governance Leadership

Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study Overview Pfizer is running a Phase 2 trial called “A PHASE 2, DOUBLE-B...

Pfizer Ends Mid-Stage Lupus Skin Trial, Trimming a Small but Promising Autoimmune Option

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Core Scientific Inc (CORZ – Research Report) and Fre...

Analysts Are Bullish on Top Technology Stocks: Core Scientific Inc (CORZ), Frequency Electronics (FEIM)

Forum Energy Tech ( ($FET) ) has provided an update. On January 12, 2026, Forum Energy Technologies, Inc. appointed The Honorable Leslie A. Beyer t...

Forum Energy Tech Appoints Leslie Beyer to Board

Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study OverviewThis Phase 3 Pfizer study, officially titled “AN INTERVENTIONA...

Pfizer’s New Colorectal Cancer Trial Puts PF-08634404 Head-to-Head With a Market Standard

Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study Overview Pfizer is running a late-stage clinical study called “A Phase...

Pfizer’s Phase 3 C. Difficile Vaccine Study Targets a New Niche in the Adult Vaccine Market

Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study Overview Pfizer is running a global Phase 2/3 trial called “A GLOBAL P...

Pfizer Advances New Lung Cancer Combo in Global Phase 2/3 Trial: What Investors Should Watch

Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study Overview: Pfizer is running a large, long-term phase 3 trial (NCT03422...

Pfizer’s Abrocitinib Atopic Dermatitis Study Nears Data Milestone: What Investors Should Watch

Ferrari ( ($IT:RACE) ) has issued an update. On January 12, 2026, Ferrari reported on the execution of the first tranche of its €250 million share ...

Ferrari Details First Week Activity of €3.5 Billion Multi-Year Share Buyback Program

Tempus AI’s ($TEM) preliminary results show its total contract value (TCV) surpassed $1.1 billion, marking the highest level in its history. The up...

Tempus AI (TEM) Tops $1.1B in Total Contract Value as Pharma Demand for AI Tools Surges

The latest announcement is out from Brookside Energy ( ($AU:BRK) ). Brookside Energy Limited has provided an update on its on-market share buy-back...

Far East Gold Ltd ( ($AU:FEG) ) has shared an update. Far East Gold has reported further bonanza-grade gold results from its ongoing 10-hole diamon...

Far East Gold Extends Bonanza-Grade Gold Zone at Papua’s Sua Prospect

Kepler Capital analyst Thomas Besson maintained a Buy rating on Ferrari on January 9 and set a price target of €400.00. The company’s shares closed...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	FE	$46.63	+0.18%	3.24M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	FE	$46.63	+0.2%	3.24M
3
4
5
6

FE

FE

Get FirstEnergy Corp. Data in Excel

Get FirstEnergy Corp. Data in Excel